It is suggested that serum IL-6, CRP, and sCD40L may be involved in the pathological process of CHD in patients with T2DM, and the more severe the CHD is, the higher the expression level of serum IL-6, CRP, and sCD40L is. This evidence concerns the gene IL6 and coronary artery disorder.